Thomas Foltynie
Thomas Foltynie
Senior Lecturer, UCL Institute of Neurology
Verified email at - Homepage
Cited by
Cited by
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
The Lancet Neurology 18 (12), 1091-1102, 2019
Adaptive deep brain stimulation in advanced Parkinson disease
S Little, A Pogosyan, S Neal, B Zavala, L Zrinzo, M Hariz, T Foltynie, ...
Annals of neurology 74 (3), 449-457, 2013
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
CH Williams-Gray, T Foltynie, CEG Brayne, TW Robbins, RA Barker
Brain 130 (7), 1787-1798, 2007
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
CH Williams-Gray, JR Evans, A Goris, T Foltynie, M Ban, TW Robbins, ...
Brain 132 (11), 2958-2969, 2009
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis
D Aarsland, K Bronnick, C Williams-Gray, D Weintraub, K Marder, ...
Neurology 75 (12), 1062-1069, 2010
The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study
T Foltynie, CEG Brayne, TW Robbins, RA Barker
Brain 127 (3), 550-560, 2004
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
CH Williams-Gray, SL Mason, JR Evans, T Foltynie, C Brayne, ...
Journal of Neurology, Neurosurgery & Psychiatry 84 (11), 1258-1264, 2013
Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach
SJG Lewis, T Foltynie, AD Blackwell, TW Robbins, AM Owen, RA Barker
Journal of Neurology, Neurosurgery & Psychiatry 76 (3), 343-348, 2005
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
D Athauda, K Maclagan, SS Skene, M Bajwa-Joseph, D Letchford, ...
The Lancet 390 (10103), 1664-1675, 2017
Parkinson’s disease dementia: a neural networks perspective
J Gratwicke, M Jahanshahi, T Foltynie
Brain 138 (6), 1454-1476, 2015
Exenatide and the treatment of patients with Parkinson’s disease
I Aviles-Olmos, J Dickson, Z Kefalopoulou, A Djamshidian, P Ell, ...
The Journal of clinical investigation 123 (6), 2730-2736, 2013
Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients
A Eusebio, W Thevathasan, LD Gaynor, A Pogosyan, E Bye, T Foltynie, ...
Journal of Neurology, Neurosurgery & Psychiatry 82 (5), 569-573, 2011
Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson’s disease
V Litvak, A Jha, A Eusebio, R Oostenveld, T Foltynie, P Limousin, L Zrinzo, ...
Brain 134 (2), 359-374, 2011
Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy
S Lesage, V Drouet, E Majounie, V Deramecourt, M Jacoupy, A Nicolas, ...
The American Journal of Human Genetics 98 (3), 500-513, 2016
Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review
L Zrinzo, T Foltynie, P Limousin, MI Hariz
Journal of neurosurgery 116 (1), 84-94, 2012
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden, R Kraaij, J Jankovic, ...
Brain 140 (12), 3191-3203, 2017
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
A Beilina, IN Rudenko, A Kaganovich, L Civiero, H Chau, SK Kalia, ...
Proceedings of the National Academy of Sciences 111 (7), 2626-2631, 2014
Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging
C Lambert, L Zrinzo, Z Nagy, A Lutti, M Hariz, T Foltynie, B Draganski, ...
Neuroimage 60 (1), 83-94, 2012
Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports
Z Kefalopoulou, M Politis, P Piccini, N Mencacci, K Bhatia, M Jahanshahi, ...
JAMA neurology 71 (1), 83-87, 2014
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
A McNeill, J Magalhaes, C Shen, KY Chau, D Hughes, A Mehta, ...
Brain 137 (5), 1481-1495, 2014
The system can't perform the operation now. Try again later.
Articles 1–20